Scientists have uncovered previously unknown immune structures in the skull bone marrow of mice that may act as a rapid first line of defense against brain cancer. Published in the journal Nature, the study suggests these local immune hubs could enhance the body’s ability to reject tumors and improve survival. Researchers from Washington University School of Medicine in St. Louis identified these structures, which resemble lymph nodes, and found similar immune cells in human skull bone marrow, hinting that this defense system may not be unique to mice. This discovery builds on earlier research from the same lab, which challenged the traditional belief that the brain was completely isolated from the immune system. Scientists previously found lymphatic vessels in the dura mater, a protective layer surrounding the brain, and identified tiny channels connecting the skull, dura, and brain tissue. These channels allow immune cells and waste products to move between the brain and the skull bone marrow, suggesting a previously unrecognized link between the brain and the immune system. In a study using a mouse model of glioblastoma, a highly aggressive brain cancer, researchers tested the role of these skull immune hubs. They used a drug to interfere with the hubs and observed that tumors grew faster in mice with disrupted immune defenses compared to those with intact hubs. Mice whose immune hubs were impaired also had shorter lifespans, indicating that these structures actively contribute to the body's response to brain cancer. To explore whether these immune hubs could be strengthened, the researchers developed a targeted treatment. They combined three immune-boosting proteins into a gel and placed it beneath the scalp. The treatment triggered a strong immune response against the tumors, with the reaction first appearing in the skull bone marrow’s immune hubs before spreading to nearby lymph nodes. Mice treated with the gel showed better tumor rejection and longer survival compared to untreated animals. The implications of this discovery extend beyond brain cancer. Since these immune hubs are located directly next to the brain, they may offer a way to influence immune activity in neurological diseases without affecting the rest of the body. The findings suggest that the brain not only interacts with immune cells but may also have specialized immune "security stations" positioned unusually close to it, opening new possibilities for targeted therapies.